Calpain-induced proteolysis of β-spectrins  by Löfvenberg, Lars & Backman, Lars
Calpain-induced proteolysis of L-spectrins
Lars Loºfvenberg, Lars Backman*
Department of Biochemistry, Umeaî University, S-901 87 Umeaî, Sweden
Received 17 November 1998; received in revised form 17 December 1998
Abstract The calcium-activated neutral protease calpain is
activated in several pathological conditions. Calpain usually
hydrolyses one or only a few peptide bonds in its substrate. One
prominent substrate for calpain is spectrin and it has been shown
that K-spectrin is the preferred substrate. We now show that the
L-chain of spectrin is also a substrate for calpain proteolysis, and
that the cleavage site in each L-subunit is located at the very C-
terminal part of the molecule. Surprisingly, LI41-spectrin is
cleaved at a different site than LI42- and LII41-spectrins despite
their high degree of sequence identity.
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1. Introduction
Injury or lack of oxygen supply in the animal brain leads to
a rise in the concentration of the neurotransmitter glutamate
[1]. The increased level of glutamate acts on N-methyl-D-as-
partate receptors, to open an ion channel that allows in£ux of
calcium from the extracellular medium. The elevation of cy-
toplasmic calcium activates calpain proteases as well as mod-
ulating the activities of a wide variety of calcium-binding pro-
teins.
One well-known substrate for the calpain proteases is spec-
trin [2^4]. The breakdown of spectrin in response to ischaemia
has revealed that spectrin proteolysis by calpains closely par-
allels nerve damage [2,5^8]. Calpain inhibitors administered to
animals before induction of ischaemia both inhibit spectrin
proteolysis and protect the animals from the spreading of
cell death [9,10].
Spectrin is a multifunctional protein, containing several dis-
tinct recognition sites for other proteins, such as actin, protein
4.1, ankyrin, adducin, calmodulin and synapsins [11^14].
Moreover, spectrin also contains src [15,16], pleckstrin
[17,18] and calponin homology domains [19], indicating a
role in signal transduction. Spectrin is a heterodimer, formed
by antiparallel association of an V280 kDa K-chain and a
245^460 kDa L-chain [12]. Both subunits can be divided into
three domains: the N- and C-terminal domains and the repeat
domain. The repeat domain consists of several repeats of 106
amino acid residues long, each folded into a triple-helical
structure and connected to each other by a short, £exible
linker. The K-chain contains 21 repeats whereas the L-chain
contains 17 such repeats [12]. The two subunits are the prod-
ucts of several distinct genes; two types of K-spectrin and at
least three types of L-spectrin are expressed in humans [12].
Recently, a third L-spectrin gene has been identi¢ed, although
its expression is unknown. The di¡erent isoforms of spectrin
show developmentally regulated expression and di¡erent sub-
cellular localisation; in neurones and glia KILI42-spectrin
(muscle spectrin) is localised to the cell body and dendrites
while KIILII (brain spectrin) is found in the axon [14,20].
Alternative transcription of the LI-spectrin gene gives rise to
KILI41-spectrin, which is found in the erythrocytes.
The function of spectrin is to link cytoskeletal ¢lament sys-
tems, including actin ¢laments, to transmembrane proteins of
the plasma membrane [12]. Spectrin, together with ankyrin,
provides a mechanism for restricting the free di¡usion of
transmembrane proteins in the plane of the membrane. Ion
channels, receptors and cell adhesion molecules can thereby be
retained at speci¢c points on the cell surface by their interac-
tion with the cytoplasmic structural apparatus. The connec-
tion of the plasma membrane to the cytoskeleton also pro-
vides a mechanism for generation of cell shape as well as
mechanical stability. Therefore, any process that changes the
properties of spectrin will also a¡ect the general properties of
the cell. This is illustrated by the ¢nding that certain muta-
tions in the spectrin genes are lethal [21,22].
Despite the knowledge of the general basis of membrane-
cytoskeleton interaction, the precise connection between dis-
ruption of the spectrin-ankyrin system and cell death remains
unknown. In part this is due to de¢ciencies in the knowledge
of the biochemistry and molecular biology of this system.
Previous work has shown that KII-spectrin but not KI-spectrin
is hydrolysed by calpain at a site in repeat 11, giving rise to
two nearly equal fragments of V150 kDa. In the presence of
calmodulin, also LII-spectrin is cleaved by calpain into frag-
ments of 165 and 125 kDa [23]. In this report, we have studied
the calpain-induced proteolysis of L-spectrin C-termini, in or-
der to identify the speci¢city of the proteolytic enzyme. The
results show that all three isoforms of L-spectrin are hydro-
lytically cleaved in the C-terminus by calpain although calpain
acts on di¡erent peptide bonds.
2. Material and methods
2.1. Isolation of L-spectrin C-terminal gene fragments
The LI41 and LII41 clones were isolated from a human foetal liver
cDNA library (Clontech) by PCR using appropriate primers. The
following primers were used: LII41 forward: GGC GGC CTA
CCC GGG TGA CAA GG (bp 5923^5945, XmaI), LII41 reverse:
GGT AAG AGA AGC CCG GGA GGT GAA GG (bp 7414^
7439, XmaI), LI41 forward: C CAG GAC GTG GGA TCC CGT
CTG C (bp 5660^5682, BamHI) and LI41 reverse: GC TGC GGA
ATT CAT CTC GCC TCC (bp 6522^6544, EcoRI). (In the primers
used, restriction sites for XmaI, BamHI or EcoRI were introduced.
Bold letters indicate introduced mismatches.) Ampli¢ed DNA was
isolated from agarose gels, digested with XmaI, BamHI or EcoRI
and ¢nally puri¢ed by a gene puri¢cation system (QIAquick Gel Ex-
traction Kit, Qiagen or GeneClean, Bio 101). Fragments were ligated
into the appropriate restriction site of the pGEX-2T vector. These
plasmids were then used to transform Escherichia coli strain JM109.
Upon puri¢cation, using glutathione-Sepharose, it turned out that
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the C-termini of the two L-spectrins were unstable and were degraded
fairly quickly. Therefore, the gene fragments were excised by PCR
from these plasmids using the following primers: LII41 forward:
GTG CCA TGG CCG ACG ATA TCC (bp 5937^5957, NcoI),
LII41 reverse: GGA GAT CTT TTT CTT TTT GCC AAA AAG
G (bp 7382^7410, BglII), LI41 forward: TCT GCA GGG ATC CTA
TGC TGG GG (bp 5678^5700, BamHI) and LI41 reverse: TAG
GGG TGA GAT CTC CTC TGG CTG C (bp 6482^6505, BglII).
The fragments were puri¢ed from agarose gels as before and ligated
into pQE-60 expression vector (Qiagen). In this system, a 6UHis
a⁄nity tag is fused to the C-terminus of the expressed peptide. The
6UHis a⁄nity tag allows for simple puri¢cation on chelating Sephar-
ose (Amersham Pharmacia Biotech AB) saturated with Ni2. The
produced C-terminal peptides of LI41 and LII41 include codons
1898^2137 and 1881^2366, respectively.
The plasmid for the C-terminus of LI42-spectrin (GST-LI42) was
generously provided by Dr A. Viel and yields a peptide spanning
residues 2009^2329 fused to the C-terminus of glutathione S-trans-
ferase.
2.2. Identi¢cation and expression of the recombinant proteins
Positive clones were identi¢ed by screening for expressed products
with the expected molecular mass. To verify that isolated clones were
correct, they were sequenced by the dideoxynucleotide chain termina-
tion method using the Cyclist Exo3Pfu DNA sequencing kit (Strata-
gene) or the ABI Prism Dye Terminator cycle sequencing kit (Perkin-
Elmer).
Isolated clones were grown at 23 or 30‡C in Luria-Bertani media
containing 100 Wg/ml ampicillin (or carbenicillin) until the cultures
reached mid-log phase (OD600W0.5), then protein expression was
induced by the addition of isopropyl-1-thio-L-D-galactopyranoside to
0.5 mM. After growth overnight at 23 or 30‡C the cell suspensions
were harvested by centrifugation. After resuspending the pelleted cells
in 50 mM sodium phosphate bu¡er, 300 mM NaCl, pH 8, cells were
frozen at 320‡C until puri¢cation.
2.3. Puri¢cation of L-spectrins
His-tagged fusion proteins were isolated from frozen cell suspen-
sions. Thawed and pelleted cells were resuspended in 50 mM sodium
phosphate bu¡er, 300 mM NaCl, pH 8, containing 8 M urea, followed
by sonication. Triton X-100 was added to a ¢nal concentration of 1%
and then the lysate was incubated for 1 h on ice before it was centri-
fuged (48 000Ug for 10 min). The supernatant was carefully removed
and applied to a Ni2-saturated chelating Sepharose 4B column. After
washing the column with 50 mM sodium phosphate bu¡er, 300 mM
NaCl, pH 8, contaminants were eluted with 100 (LI41) or 50 (LII41)
mM imidazole in 50 mM sodium phosphate bu¡er, 300 mM NaCl,
pH 8. LI41- and LII41-spectrin C-termini were eluted with 50 mM
EDTA in 25 mM sodium phosphate bu¡er, 150 mM NaCl, pH 8.
To purify GST-LI42, cells suspended in 50 mM sodium phosphate
bu¡er, 300 mM NaCl, pH 8, were thawed and sonicated. After in-
cubation with 1% Triton X-100 for 1 h on ice and centrifugation
(27 000Ug for 10 min), GST-LI42 was puri¢ed on glutathione-Sephar-
ose (Amersham Pharmacia Biotech AB). Bound material was eluted
with 10 mM glutathione in 50 mM sodium phosphate bu¡er, 300 mM
NaCl, pH 8, 1 mM EDTA and 150 WM PMSF.
2.4. Electrophoresis and immunoblotting
Isolated recombinant peptides were analysed by SDS-PAGE [24]
and Western blotting using anti-6UHis monoclonal antibody (Clon-
tech) or INDIA HisProbe-HRP (Pierce) as well as an anti-LI42-spec-
trin antibody (generous gift from T. Petrucci).
Calpain-induced proteolysis was analysed by electrophoresis under
denaturing conditions using either the Laemmli bu¡er system or a
tricine-based bu¡er system designed for the separation of low molec-
ular weight proteins [25].
2.5. Calpain cleavage
Recombinant peptides were dialysed in 25 mM sodium phosphate
bu¡er, 150 mM NaCl, pH 8, before proteolysis. 3^10 WM L-spectrin
peptides were cleaved by adding calpain I (Calbiochem) to 10 Wg/ml
and CaCl2 to 0.2 mM. Samples, incubated at 25‡C, were withdrawn at
indicated times and immediately added to SDS-PAGE cocktail and
boiled for 3 min to stop the reaction.
2.6. N-terminal sequencing
After separation on tricine SDS-PAGE, proteolytic fragments were
transferred to PVDF membranes by semi-dry blotting. Coomassie
blue-stained bands were excised and subjected to N-terminal sequenc-
ing to identify hydrolytic products and calpain cleavage sites.
2.7. Modelling of spectrin repeat unit
MultiAlin [26] was used to align amino acid sequences of the L-
spectrin isoforms with the repeat sequence of K-spectrin. The structure
of the incomplete L17 repeat units of LI41 and LII41 was modelled on
the known structure of repeat unit 16 of K-chicken spectrin (PDB ID:
1AJ3) [27] using the SWISS model [28].
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Fig. 1. Calpain-induced degradation of spectrin. A: LI41- (lanes 1^
4) and LII41-spectrin (lanes 6^8) were degraded by calpain (10 Wg/
ml) at 25‡C. Samples were withdrawn after the indicated time,
mixed with SDS cocktail, boiled for 3 min and analysed by 16%
SDS-PAGE. Lane 1: 0 min; lane 2: 1 min; lane 3: 3 min; lane 4:
10 min; lane 5: molecular weight standards, from top to bottom:
94, 67, 43, 30, 20 and 14 kDa; lane 6: 0 min; lane 7: 10 min; and
lane 8: 180 min. B: LI42-spectrin was degraded similarly, and cleav-
age products were analysed by 13.5% SDS-PAGE. Lane 1: 0 min;
lane 2: 1 min; lane 3: 3 min; lane 4: 10 min; lane 5: 30 min; lane
6: 90 min; lane 7: 270 min; lane 8: molecular weight standards (as
above); lane 9: 270 min in the absence of calcium; and lane 10:
270 min in the absence of calpain.
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3. Results and discussion
When the isolated recombinant L-spectrin C-termini were
incubated in the presence of calpain and calcium, all three
isoforms were cleaved proteolytically, as shown in Fig. 1.
The initial 35 kDa LI41-spectrin gave rise to two major frag-
ments, as expected, with molecular sizes of about 12 and 23
kDa. The 60 kDa LII41-peptide gave rise to a 40 kDa frag-
ment as well as two smaller fragments of 18 and 22 kDa. The
reason for the occurrence of two and not a single smaller
peptide is unknown. It is possible that there are other proteo-
lytic sites becoming accessible upon the initial calpain cleav-
age. The muscle L-spectrin was also degraded by calcium-ac-
tivated calpain, though in this case the initial 65 kDa GST-
LI42 was cleaved into two peptides of around 30 and 37 kDa.
Thus, in all cases, the sizes of the produced fragments add up
to the initial size of the peptide.
The C-terminal products of LI41, LI42 and LII41 after
proteolysis were separated by SDS-PAGE, transferred to
PVDF membranes, excised and subjected to N-terminal se-
quencing. The results indicated that these isoforms were not
cleaved at one single site in the C-termini (Fig. 2). Alignment
of the sequences, both with the three L-spectrin isoforms and
with the putative repeat structure, implies not only that there
is a di¡erence in the calpain-dependent proteolytic sites but
also that these sites are located to a suggested helical region
and not, as expected, to a turn or linker region.
Although the recognition sites of calpain substrates prob-
ably involve higher orders of structure some features appear
to be common: there is usually a large aliphatic or aromatic
side chain at position 1, 2, or 3 at the N-terminal side and a
basic or large aliphatic residue at position 1 at the C-terminal
side of the cleavage site [29]. The cleavage of LI41 and LI42
seemed to follow this as they were cleaved after tryptophan
and threonine, respectively, contrary to LII41 which was hy-
drolysed between two alanines.
The di¡erence in cleavage site may depend on slight di¡er-
ences in structure of the isoforms. We have applied molecular
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Fig. 2. Alignment of LI41-, LI42- and LII41-spectrin. The C-termini of the three isoforms of L-spectrin were aligned using MultiAlin according
to the suggested phasing of the repeat units of K-spectrin. The three K-helices (A, B and C) are indicated above the sequence. Bold letters indi-
cate calpain cleavage sites.
Fig. 3. Models of the incomplete repeat unit 17 of LI41- and LII41-
spectrin. The structures of the incomplete L17 repeat units of LI41
(middle) and LII41 (upper) were calculated by the SWISS model us-
ing the known structure of repeat 16 of chicken brain K-spectrin
(lower). Arrows indicate the new C-terminal amino acid residues
after cleavage.
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modelling [28] on repeat 17 of the L-spectrins to investigate
this further, using the known structure of repeat 16 of chicken
K-spectrin [27] as a template. Circular dichroism measure-
ments indicated a high helical content [30], implying that the
N-termini, containing repeats 16 and 17, are K-helical whereas
the C-termini are much less ordered. Secondary structure pre-
diction analysis of the peptides also supported this suggestion.
Although repeat 17 probably is mostly K-helical, there is no
evidence as to whether this repeat folds independently into an
incomplete triple-helical structure or not. However, the mod-
elling indicated, as shown in Fig. 3, that not all residues of the
suggested helix B of repeat L17 may fold into a helix, when
modelled on K16; in both LI41- and LII41-spectrins only the
N-terminal half of the suggested helix B appeared to fold into
a helical structure. Helix B seemed to be incomplete in both
cases compared to K16 and it was apparent that helix B of
repeat 17 in LI41 was longer than that of LII41. The models
of L17 also indicated that the determined cleavage sites would
be accessible to calpain in all three isoforms (Fig. 3) independ-
ent of the folding. However, it must be noted that the align-
ment of the repeat units of L-spectrin is based on the repeat
structure of K-spectrin. Therefore it cannot be excluded at this
stage that the suggested phasing of the L-repeat unit is incor-
rect.
Previously, we identi¢ed a calpain-like activity strongly as-
sociated with erythrocyte spectrin [31] that cleaved LI41-spec-
trin at a single site. It was not possible to isolate the released
peptide, but the size of the remaining L-chain decreased by
10^20 kDa. Since one of the peptides released from the LI41-
peptide was around 12 kDa, similar to the size calculated
from the determined cleavage site, this might indicate that
these proteolytic events are catalysed by the same activity.
This peptide is quickly degraded further, which may explain
why it was not possible to isolate it in the previous studies
[31].
It has been shown that in KIILII-spectrin, only the KII-
chain is cleaved by calpain and that proteolysis of the LII-
chain also requires the presence of calmodulin [23]. In con-
trast, in erythrocyte spectrin only the LI-chain but not the KI-
chain is degraded by calpain [31]. It has been suggested [23]
that calmodulin and calpain co-ordinately regulate the inter-
action of KIILII-spectrin with actin and that as long as the L-
chain is intact spectrin is still able to cross-link actin ¢laments.
Since the spectrin isoforms show di¡erent subcellular local-
isation [14,20] and since the calpain site in the K-chain is
missing in KILI-spectrin [32], it is possible that in neurones
the e¡ect of calpain-induced proteolysis is di¡erent in the
axon compared to the cell body and dendrites. Further studies
of the di¡erent spectrin isoforms and their susceptibility to
calpain with the objective of understanding the molecular de-
tails of the calpain-induced degradation of spectrin are in
progress.
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